ArticlePatterns (New York, N.Y.)2025
Hierarchical affinity landscape navigation through learning a shared pocket-ligand space.
Article in Patterns (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Atomic-level protein-ligand recognition with PBCNet2.0 for probe discovery.Nature chemical biology · 2026Article
- SCORCH2: A Generalized Heterogeneous Consensus Model for High-Enrichment Interaction-Based Virtual Screening.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The structure of the protein binding pocket governs the ligand binding affinity by providing crucial intermolecular interactions and spatial compatibility. While existing methods have leveraged these structural insights to advance affinity prediction, they often treat virtual screening and hit-to-lead optimization separately, mainly due to incompatible speed-accuracy requirements. However, these two tasks complement each other, and their integration enables broader chemical exploration while preserving focus on affinity-determining substructures. Here, we present ligand unified affinity (LigUnity), a foundation model for affinity prediction that jointly embeds ligands and pockets into a shared space. In particular, LigUnity learns coarse-grained active/inactive distinction through scaffold discrimination and fine-grained pocket-specific ligand preference through pharmacophore ranking. We demonstrate the effectiveness and versatility of LigUnity on eight benchmarks across six settings. In virtual screening, LigUnity outperforms 24 methods with >50% improvement and demonstrates robust generalization to novel targets. In hit-to-lead optimization, it achieves state-of-the-art performance across split-by-time, split-by-scaffold, and split-by-unit settings, emerging as a cost-efficient alternative to free energy perturbation. We further showcase how LigUnity can be employed in an active learning framework for tyrosine kinase 2 (TYK2) to efficiently find optimal ligands. Collectively, these results establish LigUnity as a versatile foundation model for affinity prediction, offering broad applicability across the drug discovery pipeline.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.